BRIEF-Biofrontera announces sale of license to Xepi Antibiotic Cream to Pelthos Therapeutics for up to $10 Million

Reuters11-07

BRIEF-Biofrontera announces sale of license to Xepi Antibiotic Cream to Pelthos <a href="https://laohu8.com/S/LENZ">Therapeutics</a> for up to $10 Million

Nov 7 (Reuters) - Biofrontera Inc BFRI.O:

BIOFRONTERA INC. ANNOUNCES SALE OF LICENSE TO XEPI® ANTIBIOTIC CREAM TO PELTHOS THERAPEUTICS INC. FOR UP TO $10M
BIOFRONTERA INC - DEAL EXPECTED TO FUND BIOFRONTERA TO PROFITABILITY

Source text: ID:nGNXc0jXQj

Further company coverage: BFRI.O

((Reuters.Briefs@thomsonreuters.com;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2581883583?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-11-07 21:11","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2581883583","market":"us","top_or_hot":-1,"title":"BRIEF-Biofrontera announces sale of license to Xepi Antibiotic Cream to Pelthos Therapeutics for up to $10 Million","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BRIEF-Biofrontera announces sale of license to Xepi Antibiotic Cream to Pelthos <a href=\"https://laohu8.com/S/LENZ\">Therapeutics</a> for up to $10 Million</title></head><body><p><span>Nov 7 (Reuters)</span><span> - </span><a href=\"https://laohu8.com/S/BFRI\">Biofrontera Inc</a> <span>BFRI.O</span>:</p><ul><li><p>BIOFRONTERA INC. ANNOUNCES SALE OF LICENSE TO XEPI® ANTIBIOTIC CREAM TO <a href=\"https://laohu8.com/S/PTHS\">PELTHOS THERAPEUTICS INC</a>. FOR UP TO $10M</p></li><li><p>BIOFRONTERA INC - DEAL EXPECTED TO FUND BIOFRONTERA TO PROFITABILITY</p></li></ul><p>Source text: <span>ID:nGNXc0jXQj</span></p><p>Further company coverage: <span>BFRI.O</span></p><p> ((Reuters.Briefs@thomsonreuters.com;))</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BRIEF-Biofrontera announces sale of license to Xepi Antibiotic Cream to Pelthos Therapeutics for up to $10 Million</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBRIEF-Biofrontera announces sale of license to Xepi Antibiotic Cream to Pelthos Therapeutics for up to $10 Million\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2025-11-07 21:11</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BRIEF-Biofrontera announces sale of license to Xepi Antibiotic Cream to Pelthos <a href=\"https://laohu8.com/S/LENZ\">Therapeutics</a> for up to $10 Million</title></head><body><p><span>Nov 7 (Reuters)</span><span> - </span><a href=\"https://laohu8.com/S/BFRI\">Biofrontera Inc</a> <span>BFRI.O</span>:</p><ul><li><p>BIOFRONTERA INC. ANNOUNCES SALE OF LICENSE TO XEPI® ANTIBIOTIC CREAM TO <a href=\"https://laohu8.com/S/PTHS\">PELTHOS THERAPEUTICS INC</a>. FOR UP TO $10M</p></li><li><p>BIOFRONTERA INC - DEAL EXPECTED TO FUND BIOFRONTERA TO PROFITABILITY</p></li></ul><p>Source text: <span>ID:nGNXc0jXQj</span></p><p>Further company coverage: <span>BFRI.O</span></p><p> ((Reuters.Briefs@thomsonreuters.com;))</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BFRI","symbol_name":"Biofrontera Inc","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251107:nTUA1LSRRQ:1","article_id":"2581883583","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2581883583","pubTimestamp":1762521079,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"BRIEF-Biofrontera announces sale of license to Xepi Antibiotic Cream to Pelthos Therapeutics for up to $10 MillionNov 7 (Reuters) - Biofrontera Inc BFRI.O:BIOFRONTERA INC. ANNOUNCES SALE OF LICENSE TO","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BFRI":"Biofrontera Inc","BK4007":"制药","BFRIW":"Biofrontera Inc Warrant"},"translate_title":"简介-Biofrontera宣布以高达1000万美元的价格向Pelthos Therapeutics出售Xepi抗生素乳膏的许可","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"BFRI":0.9,"BFRIW":0.9},"content_text":"BRIEF-Biofrontera announces sale of license to Xepi Antibiotic Cream to Pelthos Therapeutics for up to $10 MillionNov 7 (Reuters) - Biofrontera Inc BFRI.O:BIOFRONTERA INC. ANNOUNCES SALE OF LICENSE TO XEPI® ANTIBIOTIC CREAM TO PELTHOS THERAPEUTICS INC. FOR UP TO $10MBIOFRONTERA INC - DEAL EXPECTED TO FUND BIOFRONTERA TO PROFITABILITYSource text: ID:nGNXc0jXQjFurther company coverage: BFRI.O ((Reuters.Briefs@thomsonreuters.com;))","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"corporation,event","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2581883583","isCrawlerRequest":true}